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Abstract
Background: Early drain removal when postoperative day (POD) 1 drain fluid amylase (DFA) 
was ≤ 5000 U/L reduced complications in a previous randomized controlled trial. We hypothesized 
that most surgeons continue to remove drains late and this is associated with inferior outcomes.
Methods: We assessed the practice of surgeons in a prospectively maintained pancreas surgery 
registry to determine the association between timing of drain removal with demographics, co-
morbidities, and complications. We selected patients with POD1 DFA ≤ 5000 U/L and excluded 
those without drains, and subjects without data on POD1 DFA or timing of drain removal. Early 
drain removal was defined as ≤ POD5.
Results: 244 patients met inclusion criteria. Only 90 (37%) had drains removed early. Estimated 
blood loss was greater in the late removal group (190 mL vs 100 mL, p = 0.005) and pathological 
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findings associated with soft gland texture were more frequent (97(63%) vs 35(39%), p < 0.0001). 
Patients in the late drain removal group had more complications (84(55%) vs 30(33%), p = 0.001) 
including pancreatic fistula (55(36%) vs 4(4%), p < 0.0001), delayed gastric emptying (27(18%) 
vs 3(3%), p = 0.002), and longer length of stay (7 days vs 5 days, p < 0.0001). In subset analysis 
for procedure type, complications and pancreatic fistula remained significant for both 
pancreatoduodenectomy and distal pancreatectomy.
Conclusion: Despite level 1 data suggesting improved outcomes with early removal when POD1 
DFA is ≤ 5000 U/L, experienced pancreas surgeons more frequently removed drains late. This 
practice was associated with known risk factors (EBL, soft pancreas) and may be associated with 
inferior outcomes suggesting potential for improvement.
Introduction:
Within complex pancreatic surgery, the most significant complication is a post-operative 
pancreatic fistula (POPF).1–3 Many modifications have been proposed throughout the years 
in an attempt to prevent POPF including variations in surgical technique. However, fistulas 
still occur in 10% of patients and cause significant morbidity.4 Historically, the use of 
abdominal drains mitigated that morbidity but a growing appreciation as to the unnecessary 
or detrimental nature of drains in other operations including splenectomy and gastrectomy 
called into question the use of drains in complex pancreatic surgery.4–5
Recently, concerns that drains may increase post-operative complications rather than 
mitigate them caused a decline in the usage of prophylactic abdominal drains. A poll of 
experienced pancreatic surgeons revealed that 27% elected for selective use of abdominal 
drains with 51% removing them earlier than post-operative day 3 (POD3).6 Support for this 
practice stemmed from the idea that drains provide not only a portal of entry for bacteria but 
also generate considerable negative pressure potentially causing fistula formation. However, 
post-operative day (POD) 1 drain fluid amylase (DFA) concentration greater than 5000 U/L 
has been associated with an increased risk of clinically relevant postoperative pancreatic 
fistula (CR-POPF) and in those patients, the elimination of prophylactic drains would expose 
them to considerable risk.7,8 Therefore, the selective use of intra-operative drains with early 
drain removal in patients with negligible fistula risk provides a potential solution.
However, the current literature evaluating outcomes in pancreatectomy patients after early 
drain removal is limited. Indeed, early drain removal in selected patients has been associated 
with reduced postoperative complications after pancreatectomy.9 Only one randomized 
prospective trial by Bassi and colleagues has assessed the safety of early drain removal.9 
Despite results showing improved outcomes, many surgeons remain reluctant to remove 
intraperitoneal drains early in the postoperative period. We hypothesized that in low risk 
patients (POD1 DFA ≤ 5000 U/L), late drain removal (> POD 5) would be associated with 
worse outcomes including an increased rate of CR-POPF and intra-abdominal abscess.
Methods:
We queried data from a prospectively maintained pancreas surgery registry at a high-volume 
academic pancreas center, Baylor College of Medicine, from January 2006 to December 
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2016. The electronic web-based database contains data on patient demographics, clinical 
history, past medical history, family and social history, physical exam findings, diagnostic 
tests and imaging, as well as detailed data on operative interventions and pathologic data. 
All complications within 60 days of surgery are prospectively recorded and are graded using 
the Accordion Severity Grading for Surgical Complications10 and International Study Group 
on Pancreatic Fistula (ISGPF)/International Study Group of Pancreatic Surgery (ISGPS) 
definitions for pancreatic fistula and delayed gastric emptying. 11,12 Survival is recorded up 
to 90 days for all patients and until death for patients with cancer. After obtaining informed 
consent, data is entered into the database in real time by trained data analysts under the 
supervision of the surgeons. All data are backed up by source documents and the accuracy of 
data entered to the electronic database is periodically reviewed.13 Institutional Review 
Boards at our institution granted permission to conduct this study (IRB H-38662).
In the current study, we included patients who underwent pancreatoduodenectomy or distal 
pancreatectomy, for benign and malignant disease, who had a POD1 DFA ≤ 5000 U/L. We 
excluded patients without intraperitoneal drains and those without available data on timing 
of drain removal. Baseline demographics and past medical history were obtained from the 
database. Perioperative characteristics included pancreatic texture, duct size, pathologic 
diagnosis, EBL, intra-operative transfusion requirement, American Society of 
Anesthesiologists (ASA) score, and procedure length. Complications were assessed at 60 
days. Chi square or Fisher’s exact test, when appropriate, was used to analyze categorical 
variables. For continuous variables, the student’s t-test or Mann-Whitney test were used to 
evaluate continuous variables. A p-value of < 0.05 was considered statistically significant. 
All statistical analyses were performed using SPSS v24 (IBM Corp. Armonk NY, USA).
Results:
We identified 687 patients in our database who underwent pancreatoduodenectomy or distal 
pancreatectomy. We excluded 189 patients who did not have intraperitoneal drains placed at 
the time of pancreatectomy, 146 without data on timing of drain removal, 62 without POD1 
DFA value data, and 46 with POD1 DFA > 5000 U/L. This resulted in 244 patients meeting 
inclusion criteria with a POD1 DFA ≤ 5000 U/L (Fig 1). Of these, 176 (72%) underwent 
pancreatoduodenectomy and 68 (28%) underwent distal pancreatectomy. Patients were 
divided into two groups based on timing of drain removal. Early removal was defined as on 
or before POD5 (90 (37%)), and late removal was defined as after POD5 (154, (63%)). Most 
drains in the early removal group were removed by POD 4 (POD 3–5 IQR) while in the late 
group, most were removed by POD 11 (POD 8–17 IQR). As the practice progressed, there 
was a trend toward earlier drain removal. Prior to 2010, 6.5% of drains were removed early 
which increased to 46.2% after publication of the Bassi study.9 Additionally, surgeon 
experience and case volume did not affect timing of drain removal. Three surgeons were 
studied of which 1 is junior faculty with 5 years of experience performing an average of 20 
complex pancreas surgeries a year, and 2 senior faculty both with 20 years of experience and 
an average of over 40 cases a year. The junior faculty removed the drain early in 44% of 
patients while the senior faculty removed the drain in 35% (P=0.204).
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The overall median POD1 DFA was 328 U/L (58–1270 U/L IQR). Median POD1 DFA was 
176 U/L (37–691 U/L IQR) in the early group and 599 U/L (116–1755 U/L IQR) in the late 
group (p<0.0001). POD3 DFA data was available for 98% of patients in the early drain 
removal group and 94% in the late removal group. In those with early drain removal, median 
POD3 DFA was 21.5 U/L (IQR 10–72.5) among pancreatoduodenectomies and 104 U/L 
(IQR 46–176) for distal pancreatectomies with only 4 (4%) of patients with a DFA value 
three times the upper limit of normal. Among the late removal group, median POD3 DFA 
was 154 U/L (IQR 33.5–389.5) for pancreatoduodenectomies and 236 U/L (IQR 99.5–790) 
for distal pancreatectomies with 42(27%) with an elevated DFA on POD3.
Table 1 shows the baseline characteristics of the study population. There was no significant 
difference in age, gender, ethnicity, race, or distribution of comorbidities between the early 
and late drain removal groups. Patients in the late removal group had greater EBL (190 vs 
100 ml, p=0.005) and required intra-operative transfusions more frequently (20(13%) vs 
4(4%), p=0.03). The difference in EBL persisted in subset analysis for 
pancreatoduodenectomy and distal pancreatectomy (Table 2). Patients in the late removal 
group were also more likely to have a soft pancreatic texture (92(60%) vs 44(49%), p=0.04). 
This persisted in subset analysis for pancreatoduodenectomy patients but not for distal 
pancreatectomy. Pre-operative antibiotics were variable but Ertapenem and Meropenem 
predominated with Ertapenem used significantly more in the late drain removal group (62% 
vs 77%, p=0.012) and Meropenem used in the early removal group (13(15%) vs 2(1%), 
p<0.001). Intra-operative octreotide usage was more frequent in the late removal group 
(43(28%) vs 8(9%), p<0.001) in the overall cohort and in the pancreatoduodenectomy subset 
(41(35%) vs 6(10%), p<0.001. However, operative technique was not statistically significant 
between the early and late removal groups in either pancreatoduodenectomy or distal 
pancreatectomy patients.
Overall morbidity (excluding Grade A pancreatic fistula) was higher in the late removal 
group for both pancreatoduodenectomy and distal pancreatectomy patients (Table 3). More 
patients in the late removal group had a pancreatic fistula of any grade (55(36%) vs 4(4%), 
p< 0.0001), but there was no difference in the rates of CR-POPF (ISGPF Grade B or C). In 
those with a CR-POPF, 60% (9 of 15) were diagnosed prior to POD7 all of which required 
late drain removal but only accounted for 5.8% (9 of 150) of patients with late drain 
removal. Three patients underwent early drain removal but were diagnosed with a CR-POPF 
in the second to third post-operative week. Delayed gastric emptying was also more 
prevalent in the late removal group (27(18%) vs 3(3%), p=0.002). This difference persisted 
after subset analysis based on procedure type (Table 3). The difference in length of stay 
(LOS) between the two groups was also significant, with longer LOS in the late removal 
group (7 days vs 5 days; p<0.0001). Overall, there was no difference in rate of intra-
abdominal abscess formation. However, on subset analysis for subjects undergoing distal 
pancreatectomy, late drain removal had a higher incidence of intra-abdominal abscess 
(5(14%) vs 0, p=0.05)
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Discussion:
Early drain removal following pancreatectomy when POD1 DFA was ≤ 5000 U/L resulted in 
reduced complications in a previous randomized controlled trial.9 We hypothesized that 
despite these data, most surgeons continue to remove drains late and that this is associated 
with inferior outcomes. Our retrospective study showed that experienced pancreatic surgeons 
removed drains early only 37% of the time when the POD1 DFA was ≤ 5000 U/L despite 
surgeon experience and volume. This practice was associated with known risk factors for 
pancreatic fistula, such as increased EBL and soft gland texture, and may be associated with 
inferior outcomes suggesting potential for improvement.
Drains are placed following pancreatic resection because some surgeons believe they will 
control a postoperative leak of pancreatic secretions and decrease the incidence of 
postoperative peripancreatic fluid collections, abscesses, or erosion of retroperitoneal vessels 
resulting in postoperative hemorrhage. However, some surgeons have questioned this 
position and believe that drains, particularly if left in place for a prolonged period, can erode 
into adjacent structures and increase the incidence of postoperative pancreatic fistula (POPF) 
or serve as an avenue to introduce bacteria into a sterile pancreatic fluid collection, thus 
increasing the incidence of intra-abdominal abscesses.
Kawai et al. were the first to report improved outcomes with early drain removal after 
pancreatoduodenectomy.14 In this prospective cohort study, early drain removal was defined 
as removal on POD4 and late as on or after POD8, regardless of DFA value. The rates of 
POPF (3.6% vs 23%, p=0.004) and intra-abdominal abscess (7.7% vs 38%, p=0.003) were 
significantly lower in the early removal group. The authors also reported a 17% rate of CR-
POPF in the late drain removal group compared to 2% in the early removal group.
A subsequent prospective cohort study by Adachi et al. focusing on subjects undergoing 
distal pancreatectomy also demonstrated improvement with early drain removal.15 The 
authors defined early drain removal on POD1 and late removal on ≥ POD5, early removal 
was once again favored with a 0% incidence of CR-POPF in the early group compared to 
16% in the late removal group.
The study by Bassi and colleagues randomized patients undergoing either 
pancreatoduodenectomy or distal pancreatectomy into early and late removal groups on 
POD 3.9 In this study, which provides higher level of evidence, the authors found an 
association between early drain removal and decreased rates of pancreatic fistula (early 1.8% 
vs late 26%, p=0.0001; OR 20) and intra-abdominal complications (early 12.2% vs late 
53%, p=0.001; OR 7.9).
McMillan and colleagues conducted a multicenter prospective study to evaluate a drain 
management strategy combining selective and early drain removal in 
pancreatoduodenectomy patients.16 They employed the Fistula Risk Score (FRS), which 
uses intraoperative characteristics including EBL, pancreatic duct size, gland texture, and 
pathology.17 The authors abandoned intraperitoneal drain placement in negligible-low risk 
patients and removed drains early (POD3) in those with moderate-high risk if their POD1 
DFA was ≤ 5000 U/L. The authors compared their study population to a retrospective cohort 
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and found the CR-POPF rate to be lower after implementation of the drain management 
protocol.
Beane et al. recently performed a retrospective analysis of the American College of 
Surgeons-National Surgical Quality Improvement Program (ACS-NSQIP) database on 
outcomes for early versus delayed drain removal in pancreatoduodenectomy patients.18 
Patients with POD 1 DFA ≤ 5000 U/L whose drains were removed by POD3 were 
propensity score matched with patients whose drains were removed after POD3. Early drain 
removal when POD 1 DFA was ≤ 5000 U/L was associated with reduced overall morbidity 
(35.3% vs 52.3%, p=0.01), length of stay (6 vs 8 days, p<0.01), and CR-POPF (0.9% vs 
7.9%, p=0.02).18 Despite the strengths of the study, important factors including surgeon 
experience and case volume were not included. A surgeon’s practice evolves through 
experience and newer surgeons with lower case volumes may hesitate to remove a drain 
earlier due to the concern for complications. Using an institutional database, we were able to 
perform granular analysis and show that surgeon experience did not contribute to timing of 
removal.
These previous studies suggest that late drain removal in subjects at a lower risk for fistula 
may increase the occurrence of complications including fistula and intra-abdominal abscess. 
However, in the current study, surgeons removed drains late even in the subset of patients 
with POD1 DFA ≤ 5000 U/L. The overall median POD1 DFA in our study suggests that, if 
POD1 DFA value was not very low, surgeons may have been concerned about early drain 
removal as evidenced by a greater percentage of patients with an elevated POD3 amylase 
levels in the late group (27%) vs the early group (4%). Additionally, patient specific factors 
such as EBL, soft pancreatic texture, or concerns regarding the pancreatic anastomosis or 
transection line may have influenced their clinical decision to leave drains in place longer 
despite a low POD1 DFA. These factors could not be thoroughly assessed in this 
retrospective study. Another potential bias, given the retrospective nature of this study, is 
evolution of practice, as time progressed surgeons elected to remove drains early more often. 
The higher morbidity in the late removal group supports the concept that prolonged use of 
drains could be detrimental in patients at low risk of pancreatic fistula based on POD1 DFA 
concentration. An alternative explanation is that, perhaps driven by other patient specific 
characteristics signifying increased POPF risk, surgeons made wise decisions to leave drains 
in place since these patients indeed more frequently went on to have complications. The 
retrospective nature of this study does not allow us to measure all factors that come together 
in aggregate to influence surgical decision making.
In this retrospective study, we demonstrated that experienced pancreas surgeons frequently 
choose to remove drains late when POD1 DFA is ≤ 5000 U/L despite level 1 data suggesting 
improved outcomes with early removal. This practice was associated with inferior outcomes 
suggesting potential for improvement. We conclude that early drain removal should be 
encouraged when POD1 DFA is ≤ 5000 U/L. Data from additional multicenter randomized 
prospective trials may be needed to disseminate this change in surgical practice.
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Figure 1. 
Patient Selection Strategy
IP: Intraperitoneal
POD: Postoperative day
DFA: Drain fluid amylase
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